These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. [Comment from tHE cardiologic-angiologic viewpoint]. Rosemann A Praxis (Bern 1994); 2011 Jul; 100(14):857-8. PubMed ID: 21732298 [No Abstract] [Full Text] [Related]
5. Therapeutic efficacy of the lipid-lowering armamentarium: the clinical benefits of aggressive lipid-lowering therapy. Hunninghake DB Am J Med; 1998 Feb; 104(2A):9S-13S. PubMed ID: 9550501 [TBL] [Abstract][Full Text] [Related]
6. Intensive cholesterol lowering: no longer a myth. Bitzur R; Harats D Isr Med Assoc J; 2005 Dec; 7(12):816-7. PubMed ID: 16382708 [No Abstract] [Full Text] [Related]
8. Novel approaches to lipid lowering: what is on the horizon? Brown WV Am J Cardiol; 2001 Mar; 87(5A):23B-27B. PubMed ID: 11256846 [TBL] [Abstract][Full Text] [Related]
9. [Statins in primary prevention of coronary heart disease]. Paulweber B Wien Med Wochenschr; 1999; 149(5-6):129-38. PubMed ID: 10408004 [TBL] [Abstract][Full Text] [Related]
10. Effectiveness of statins in acute coronary syndromes. Foody JM; Nissen SE Am J Cardiol; 2001 Aug; 88(4A):31F-5F. PubMed ID: 11520485 [TBL] [Abstract][Full Text] [Related]
11. Efficacy and safety of cholesterol-lowering treatment. Law M; Wald NJ Lancet; 2006 Feb; 367(9509):469-70; author reply 470-1. PubMed ID: 16473115 [No Abstract] [Full Text] [Related]
12. Lowering LDL cholesterol: questions from recent meta-analyses and subset analyses of clinical trial DataIssues from the Interdisciplinary Council on Reducing the Risk for Coronary Heart Disease, ninth Council meeting. Gotto AM; Grundy SM Circulation; 1999 Mar; 99(8):E1-7. PubMed ID: 10051310 [TBL] [Abstract][Full Text] [Related]
13. Aggressive lipid lowering in postcoronary angioplasty patients with elevated cholesterol (the Lovastatin Restenosis Trial). Boccuzzi SJ; Weintraub WS; Kosinski AS; Roehm JB; Klein JL Am J Cardiol; 1998 Mar; 81(5):632-6. PubMed ID: 9514463 [TBL] [Abstract][Full Text] [Related]
15. Medical lipid-regulating therapy: current evidence, ongoing trials and future developments. Evans M; Roberts A; Davies S; Rees A Drugs; 2004; 64(11):1181-96. PubMed ID: 15161326 [TBL] [Abstract][Full Text] [Related]
16. Benefits of atorvastatin in cholesterol lowering. Farmer JA Curr Atheroscler Rep; 2003 Mar; 5(2):94-5. PubMed ID: 12573192 [No Abstract] [Full Text] [Related]
17. Results of recent large cholesterol-lowering trials and implications for clinical management. Gotto AM Am J Cardiol; 1997 Jun; 79(12):1663-6. PubMed ID: 9202359 [TBL] [Abstract][Full Text] [Related]
18. New LDL-cholesterol lowering therapies: pharmacology, clinical trials, and relevance to acute coronary syndromes. Sahebkar A; Watts GF Clin Ther; 2013 Aug; 35(8):1082-98. PubMed ID: 23932550 [TBL] [Abstract][Full Text] [Related]
20. Eligibility for lipid-lowering drug therapy in primary prevention: how do the Adult Treatment Panel II and Adult Treatment Panel III Guidelines compare? Gotto AM; Kuller LH Circulation; 2002 Jan; 105(2):136-9. PubMed ID: 11790688 [No Abstract] [Full Text] [Related] [Next] [New Search]